Latest Breaking News On - Katherine tuttle - Page 6 : comparemela.com

On par with the biggest breakthroughs in medicine : Spokane doctor discovers new kidney disease treatment An 11,000-person study will start in 2024

A Spokane doctor believes her team of researchers has “broken the code” to fight kidney disease with a new treatment.

United statesUnited kingdomKatherine tuttleOxford nuffield department of population healthUniversity of oxfordProvidence inland northwest healthOxford nuffield departmentUniversity schoolMedicine professor rajiv agarwalAldosterone synthase inhibitorProvidence sacred heartSacred heartHe economy

On par with the biggest breakthroughs in medicine : Spokane doctor discovers new kidney disease treatment An 11,000-person study will start in 2024

On par with the biggest breakthroughs in medicine : Spokane doctor discovers new kidney disease treatment An 11,000-person study will start in 2024
spokesman.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from spokesman.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesRajiv agarwalKatherine tuttleUniversity of oxfordOxford nuffield department of population healthProvidence inland northwest healthIndiana university school of medicineOxford nuffield departmentUniversity schoolAldosterone synthase inhibitorProvidence sacred heartSacred heart

Significant benefit seen in Phase III trial of experimental drug for kidney disease

Significant benefit seen in Phase III trial of experimental drug for kidney disease
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Katherine tuttleBoehringer ingelheimOxford population healthUniversity of washington school medicineProvidence inland northwest health in spokaneWashington schoolProvidence inland northwest health

Trial Reveals Significant Benefit of Kidney Disease Drug

Trial Reveals Significant Benefit of Kidney Disease Drug
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Katherine tuttleProvidence inland northwest health in spokaneUniversity of washington school medicineBoehringer ingelheimOxford population healthWashington schoolProvidence inland northwest health

Boehringer Ingelheim achieves major milestone in chronic kidney disease: aldosterone synthase inhibitor on top of empagliflozin delivers promising results in Phase II trial

Boehringer Ingelheim today announced promising 14-week Phase II data for BI 690517, a novel selective aldosterone synthase inhibitor (ASi). The results showed a significant reduction of albuminuria, a marker of kidney damage,2 by up to 39.5% when BI 690517 was given on top of empagliflozin, a sodium glucose .

Rheinland pfalzUnited statesCarinne brouillonKatherine tuttleJ nephrol renovascColl cardiolKidney research instituteOxford population healthAmerican society of nephrologyBoehringer ingelheimAnimal healthNephrology divisionUniversity of washingtonAmerican societyKidney weekPrincipal study investigator